
A Health Journal
Innovation in medical management will continue till there is life on earth. Last century saw the discovery of Alexander Fleming’s penicillin in 1928. While receiving the Nobel prize, he had cautioned that it will be easy for microbes to become resistant to penicillin as well if they are not exposed to sufficient dose, lethal enough to kill them. Despite the development of newer generations of antibiotics after penicillin, most are losing their efficacy due to easy accessibility and irrational use even in healthcare settings, leading to a global antimicrobial resistance crisis. Strategic steps are needed to rein in this threat.
Articles
Editorial
By – 21 January 2024
Innovation in medical management will continue till there is life on earth. Last century saw the discovery of Alexander Fleming’s penicillin in 1928. While receiving the Nobel prize, he had…
Learn MoreCounteracting Antimicrobial Resistance
By Dr. Sharmila Huda, Dr. Maliha Mannan Ahmed – 22 January 2024
Introduction Antimicrobial resistance (AMR) stands as a formidable public health menace, casting a shadow over the twenty-first century.1 This global crisis poses a substantial threat to the effectiveness of antibiotics…
Learn MoreNext Generation Sequencing Technology: Revolutionizing Diagnostics & Molecular Therapies
By Dr. Maliha Mannan Ahmed – 24 January 2024
Genomics, proteomics, and gene regulation are complex fields of human biology that hold answers to evolution, disease propagation and manifestation. The discoveries of DNAs and RNAs opened up horizons not…
Learn MoreCase Study: Successful use of plasma exchange in a case of multiple drug overdose in Bangladesh
By Dr Shihan Mahmud Redwanul Huq, Dr Raihan Rabbani, Dr. Raziuddin Ahmed, Dr. Mufizul Islam Polash, Dr Shahzadi Sayeeda Tun Nessa – 24 January 2024
Abstract Tricyclic antidepressant (TCA) and sedative overdose remains one of the most common forms of poisoning particularly in the setting of suicidal attempts. Standard of treatment in TCA poisoning is…
Learn MoreReview Article: The Evolution of Tyrosine Kinase Inhibitor in the Treatment of Non-Small Cell Lung Cancer
By Dr. Khandker Shamsul Arefin, Tamanna Sarker, Md. Tourat Hossain, Tasnuva Tanzeen, Shahanaj Akter, Tania Akter Trishna – 24 January 2024
Abstract Globally, the cancer that results in the greatest number of deaths in both sexes among all types of carcinomas is lung cancer. Once diagnosed, it has the highest rate…
Learn MoreSchool Health Record System: A Tool to Yield Demographic Dividend
By Dr. Maliha Mannan Ahmed – 24 January 2024
It is estimated that out of almost 172 million people of Bangladesh, 34.3 percent are under 15, 61.1 percent are between 15- to 64-year-olds, and 4.7 percent are above 65.…
Learn MoreKidney Disease Prevention: A Necessity to Reduce the Cost Burden of the Society
By Professor M. A. Samad – 24 January 2024
In 2018, the World Health Organization (WHO) reported kidney disease to be the 9th leading cause of death in Bangladesh, but experts currently rank it at 7th and forecasts it…
Learn MoreSafeguard Your Kidneys
By Assoc. Prof. Dr. Eusha A F Ansary, Dr. Maliha Tasnim – 24 January 2024
Introduction The National Kidney Foundation (NKF) released the Kidney Disease Outcomes Quality Initiative (KDOQI) nutrition guideline for individuals with end-stage renal disease almost two decades ago. The management of chronic…
Learn More